Skip to main content

The healthy human gut as a covert reservoir for mobile antimicrobial resistance: nationwide genomic surveillance of Enterobacter cloacae complex in China

In brief

ECC found in 1.44% of healthy Chinese people, some carrying mobile resistance genes

Researchers found Enterobacter cloacae complex in 148 of 10,300 healthy participants across China. Among the isolates, 9.5% carried carbapenemase genes, 4.1% carried mcr genes and 3.4% carried tet(X4); selected resistance genes were linked to mobile genetic elements, and transfer of blaNDM was confirmed in some isolates. The findings support community surveillance, but do not establish how often these genes spread to pathogens.

Journal
BMC microbiology (Q1)
Published
20 August 2026
Study design
Cross-sectional study
Evidence level
Level 3, Low (CEBM 3b)
Authors
Heyuan Lun, Zelin Yan, Jing Wang, Haojin Dong, Yonglu Huang, Yongning Wu, et al.
PMID
42844590
DOI
10.1186/s12866-026-05535-1

Why clinicians should know about it

  • Picked for Microbiology (medical) (paper of the day, 11 October 2026): Genomic surveillance of Enterobacter cloacae in healthy gut, AMR reservoir

Abstract

BACKGROUND: Enterobacter cloacae complex (ECC) is a formidable opportunistic pathogen, yet its ecological niche and role as a silent reservoir for antimicrobial resistance (AMR) in the healthy human gut remain underappreciated. Herein, we aim to characterize the prevalence, genomic epidemiology, and mobile resistome of ECC in a widespread healthy demographic. METHODS: In a nationwide, cross-sectional genomic surveillance study conducted across China (2024-2025), we analyzed 10,300 fecal samples from healthy individuals across 31 provinces. High-resolution whole-genome sequencing (WGS), comparative genomics, and conjugation assays were employed to resolve species identity, delineate phylogenetic relationships, and trace the mobility of high-priority resistance determinants. RESULTS: We recovered 148 non-duplicate ECC isolates, establishing a community carriage prevalence of 1.44%. Among them, Enterobacter hormaechei emerged as the predominant species (49.3%). WGS revealed a highly diverse population structure harboring critical resistance determinants, including mcr genes (4.1%), tet(X4) (3.4%), and carbapenemases (9.5%, predominantly blaNDM). Notably, this study provides, to our knowledge, the first evidence of tet(X4)-positive ECC in the gut carriage of healthy individuals in China. While mcr and tet(X4) were dispersed across diverse sequence types (STs), blaNDM carriage was strongly concentrated in specific lineages, notably ST143 and ST171. Genomic and conjugation analyses showed that tet(X4), blaNDM, and mcr were associated with conserved mobile genetic contexts (e.g., an IS1 family transposase-hydrolase-tet(X4)-IS91-like element ISVsa3 structure for tigecycline resistance), and successful transfer was confirmed for selected representative blaNDM-positive isolates. CONCLUSIONS: The healthy human gastrointestinal tract can harbor ECC isolates carrying clinically important AMR determinants, including resistance genes located within mobile genetic contexts. These findings support the integration of community-based genomic surveillance into AMR monitoring strategies to better understand asymptomatic carriage of resistant ECC.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.